使用Cox回归对事件时间结局进行个体参与者水平数据的网状Meta分析
本文综述了利用个体参与者水平数据(IPD)进行网状Meta分析(NMA)时多种Cox回归模型的设定与假设,比较了试验、治疗和协变量效应的建模方法,采用图形工具和统计检验评估比例风险假设,探讨了假设违背时扩展Cox模型的应用,并通过模拟研究和真实数据示例说明方法。
要点
- Cox回归可用于IPD-NMA,但需仔细评估比例风险假设。
- 不同Cox模型设定影响风险比、效应调节和试验异质性的解读。
- 提供实用指导以解释和报告NMA结果,并用模拟研究比较模型性能。
核心结论
- 本文系统梳理了IPD-NMA中Cox模型的设定与假设,强调比例风险假设评估的重要性,并给出解释和报告NMA结果的实用指导。
研究设计与样本
- 方法学综述与模拟研究,结合真实数据示例说明IPD-NMA的实施。
主要发现
- 比较了不同Cox模型对试验、治疗和协变量效应的建模方式及其对风险比、效应调节和试验异质性解读的影响。
- 使用多种图形工具和统计检验评估比例风险假设,并讨论其含义。
- 探讨了比例风险假设不成立时扩展Cox模型的应用。
- 通过模拟研究比较了不同模型的性能。
临床怎么用
- 原文提供了解释和报告NMA结果的实用指导,未据此给出具体临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The accessibility of individual participant-level data (IPD) enhances the evaluation of moderation effects of patient covariates. It facilitates the provision of accurate estimation of intervention effects and confidence intervals by incorporating covariate correlations across multiple clinical trials. With a time-to-event outcome, Cox regression can be applied for network meta-analysis (NMA) using IPD. However, there lacks comprehensive reviews and comparisons of the specifications and assumptions of these Cox models and their impact on the interpretation of hazard ratios, effect moderation, and trial heterogeneity in IPD-NMA. In this paper, we examine various Cox models for IPD-NMA and compare different approaches to modeling trial, treatment, and covariate effects. We employ multiple graphical tools and statistical tests to assess proportional hazard assumptions and discuss their implications. Additionally, we explore the application of extended Cox models when the proportional hazard assumption is violated. Practical guidance on interpreting and reporting NMA results is provided. A simulation study is conducted to compare the performance of different models. We illustrate the methods to conduct IPD-NMA through a real data example.
引用
- Hua K, Wojdyla D, Carnicelli A, et al. Network Meta-Analysis With Individual Participant-Level Data of Time-to-Event Outcomes Using Cox Regression. Stat Med. 2025. PMID: 39964207. doi:10.1002/sim.70027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。